Pathogenesis of liver fibrosis

Clinical Science

Volumn 92, Issue 2, 1997, Pages 103-112

  Alcolado, R ^a   Arthur, M J P ^a,b   Iredale, J P ^a  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

Author keywords

Cell matrix interaction; Hepatic stellate cells; Liver fibrosis; Martix; Matrix regulation; Tissue inhibitor of metalloproteinase 1; Transforming growth factor

Indexed keywords

ALPHA 2 MACROGLOBULIN; COLLAGEN; CYTOKINE; TISSUE INHIBITOR OF METALLOPROTEINASE; TRANSFORMING GROWTH FACTOR BETA1;

CELL PROLIFERATION; EFFECTOR CELL; EXTRACELLULAR MATRIX; HUMAN; INFLAMMATORY CELL; KUPFFER CELL; LIVER CELL; LIVER FIBROSIS; MYOFIBROBLAST; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; STELLATE CELL;

EID: 0031036886     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/cs0920103     Document Type: Review

References (121)

1. Hahn EG, Wick G, Pencev D, Timpl R. Distribution of basement membrane proteins in normal and fibrotic human liver: collagen type IV laminin and fibronectin. Gut 1980; 21: 63-71.
2. Martinez-Hernandez A. The hepatic extracellular matrix. I. Electron immunohistochemical studies in normal rat liver. Lab Invest 1984; 51: 57-69.
3. Abrahamson DR, Caulfield JP. Distribution of laminin within rat and mouse renal, splenic, intestinal, and hepatic basement membranes identified after the intravenous injection of heterologous antilaminin IgG. Lab Invest 1985; 52: 169.
4. Arenson DM, Friedman SL, Bissell DM. Formation of extracellular matrix in normal rat liver: lipocytes as a major source of proteoglycan. Gastroenterology 1988; 95: 441-7.
5. Maher JJ, Friedman SL, Roll FJ, Bissell DM. Immunolocalization of laminin in normal rat liver and biosynthesis of laminin by hepatic lipocytes in primary culture. Gastroenterology 1988; 94: 1053-62.
6. Schuppan D. Structure of extracellular matrix in normal and fibrotic liver: collagens and glycoproteins. Semin Liver Dis 1990; 10: 1-10.
7. Geerts A, Schuppan D, Lazeroms S, De-Zanger R, Wisse E. Collagen type I and III occur together in hybrid fibrils in the space of Disse of normal rat liver. Hepatology 1990; 12: 233-41.
8. Burt AD, Griffiths MR, Schuppan D, Voss B, MacSween RN. Ultrastructural localization of extracellular matrix proteins in liver biopsies using ultracryomicrotomy and immuno-gold labelling. Histopathology 1990; 16: 53-8.
9. Yurchenco PD. Assembly of basement membranes. Ann N Y Acad Sci 1990; 580: 195-214.
10. Siebold B, Deutzman R, Kuhn K. The arrangement of intra and intermolecular disulfide bonds in the carboxy terminal non collagenous aggregation and cross linking domain of basement membrane type IV collagen. Eur J Biochem 1988; 176: 617-24.
11. Yurchenco PD, Furthmayr H. Self-assembly of basement membrane collagen. Biochemistry 1984; 23: 1839-50.
12. Griffiths MR, Ferrier R, Schuppan D, Burt AD. Collagen type VI: a component of the perisinusoidal extracellular matrix in human liver. In: Wisse E, Knook DL, McCuskey RS, eds. Cells of the hepatic sinusoid. Leiden, The Netherlands: Kupffer Cell Foundation, 1991: vol. 3, 155-60.
13. Geerts A, Geuze HJ, Slot J-W, et al. Immunogold localization of procollagen III, fibronectin and heparan sulfate proteoglycan on ultrathin frozen sections of the normal rat liver. Histochemistry 1986; 84: 355-62.
14. Schuppan D, Cantaluppi MC, Becker J, et al. Undulin, an extracellular matrix glycoprotein associated with collagen fibrils. J Biol Chem 1990; 265: 8823-32.
15. Reid LM, Fiorino AS, Sigal SH, Brill S, Holst PA. Extracellular matrix gradients in the space of Disse: relevance to liver biology [Editorial]. Hepatology 1992; 15: 1198-203.
16. McGuire RF, Bissell DM, Boyles J, Roll FJ. Role of extracellular matrix in regulating fenestrations of endothelial cells isolated from normal rat liver. Hepatology 1992; 15: 989-97.
17. Rojkind M, Giambrone M-A, Biempica L. Collagen types in normal and cirrhotic liver. Gastroenterology 1979; 76: 710-19.
18. Seyer JM, Huherson ET, Kang AH. Collagen polymorphism in normal and cirrhotic human liver. J Clin Invest 1977; 59: 241-8.
19. Gressner AM, Haarmann R. Hyaluronic acid synthesis and secretion by rat liver fat storing cells (perisinusoidal lipocytes) in culture. Biochem Biophys Res Commun 1988; 151: 222-9.
20. Clement B, Laurent M, Guguen-Guillouzo C, Lebeau G, Guillouzo A. Types I and IV procollagen gene expression in cultured rat hepatocytes. Coll Relat Res 1988; 8: 349-59.
21. Maher JJ, McGuire RF. Extracellular matrix gene expression increases preferentially in rat lipocytes and sinusoidal endothelial cells during hepatic fibrosis in vivo. J Clin Invest 1990; 86: 1641-8.
22. Ramadori G, Rieder H, Knittel T, Dienes HP, Meyer zum Buschenfelde K-H. Fat storing cells (FSC) of rat liver synthesize and secrete fibronectin. J Hepatol 1987; 4: 190-7.
23. Friedman SL, Roll FJ, Boyles J, Bissell DM. Hepatic lipocytes: the principal collagen-producing cells of normal rat liver. Proc Natl Acad Sci USA 1985; 82: 8681-5.
24. Weiner FR, Giambrone MA, Czaja MJ, et al. Ito-cell gene expression and collagen regulation. Hepatology 1990; 11: 111-17.
25. Friedman SL, Rockey DC, McGuire RF, Maher JJ, Boyles JK, Yamasaki G. Isolated hepatic lipocytes and Kupffer cells from normal human liver: morphological and functional characteristics in primary culture. Hepatology 1992; 15: 234-43.
26. Kawase T, Shiratori Y, Sugimoto T. Collagen production by rat liver fat storing cells in I degree culture. Exp Cell Biol 1986; 54: 183-92.
27. Schafer S, Zerbe O, Gressner AM. The synthesis of proteoglycans in fat-storing cells of rat liver. Hepatology (Baltimore) 1987; 7: 680-7.
28. Irving MG, Roll FJ, Huang S, Bissell DM. Characterisation and culture of sinusoidal endothelium from normal rat liver, lipoprotein uptake and collagen phenotype. Gastroenterology 1984; 87: 1233-47.
29. Jarnagin WR, Rockey DC, Koteliansky VE, Wang SS, Bissell DM. Expression of variant fibronectins in wound healing: cellular sources and biological activity of the EIIIA segment in rat hepatic fibrogenesis. J Cell Biol 1994; 127: 2037-48.
30. Maher JJ, Bissell DM, Friedman SL, Roll FJ. Collagen measured in primary cultures of normal rat hepatocytes derives from lipocytes within the monolayer. J Clin Invest 1988; 82: 450-9.
31. Bissell DM, Arenson DM, Maher JJ, Roll FJ. Support of cultured hepatocytes by a laminin-rich gel. J Clin Invest 1987; 79: 801-12.
32. Bissell DM, Caron JM, Babiss LE, Friedman JM. Transcriptional regulation of the albumin gene in cultured rat hepatocytes. Role of basement-membrane matrix. Mol Biol Med 1990; 7: 187-97.
33. Iredale JP, Arthur MJP. Hepatocyte-matrix interactions. Gut 1994; 35: 729-32.
34. Friedman SL, Roll FJ, Boyles J, Arenson DM, Bissell DM. Maintenance of differentiated phenotype of cultured rat hepatic lipocytes by basement membrane matrix. J Biol Chem 1989; 264: 10756-62.
35. Friedman SL. The cellular basis of hepatic fibrosis: mechanisms and treatment strategies. N Engl J Med 1993; 328: 1828-35.
36. Horn T, Junge J, Christoffersen P. Early alcoholic liver injury. Activation of lipocytes in acinar zone 3 and correlation to degree of collagen formation in Disse space. J Hepatol 1986; 3: 333-40.
37. Mak KM, Lieber CS. Lipocytes and transitional cells in alcoholic liver disease: a morphometric study. Hepatology (Baltimore) 1988; 8: 1027-33.
38. McGee JO, Patrick RS. The role of perisinusoidal cells in hepatic fibrogenesis. An electron microscopic study of acute carbon tetrachloride liver injury. Lab Invest 1972; 26: 429-40.
39. Rockey DC, Boyles JK, Gabbiani G, Friedman SL. Rat hepatic lipocytes express smooth muscle actin upon activation in vivo and in culture. J Submicrosc Cytol Pathol 1992; 24: 193-203.
40. Mak KM, Leo AM, Lieber CS. Alcoholic liver injury in baboons: transformation of lipocytes to transitional cells. Gastroenterology 1984; 87: 188-200.
41. Leo MA, Mak KM, Savolainen ER, Lieber CS. Isolation and culture of myofibroblasts from rat liver (42193). Proc Soc Exp Biol Med 1985; 180: 382-91.
42. Shiratori Y, Ichida T, Geerts A, Wisse E. Modulation of collagen synthesis by fat-storing cells, isolated from CCI4- or vitamin A-treated rats. Dig Dis Sci 1987; 32: 1281-9.
43. Geerts A, Vrijsen R, Rauterberg J, Burt A, Schellinck P, Wisse E. In vitro differentiation of fat-storing cells parallels marked increase of collagen synthesis and secretion. J Hepatol 1989; 9: 59-68.
44. Ruoslahti E. Integrins. J Clin Invest 1991; 87: 1-5.
45. Wu C, Keivens VM, O'Toole TE, McDonald JA, Ginsberg MH. Integrin activation and cytoskeletal interaction are essential for the assembly of a fibronectin matrix. Cell 1995; 83: 715-24.
46. Dedhar S, Ruoslahti E, Pierschbacher MD. A cell surface receptor complex for collagen type I recognizes the Arg-Gly-Asp sequence. J Cell Biol 1987; 104: 585-93.
47. Stamatoglou SC, Bawumia S, Johansson S, Forsberg E, Hughes RC. Affinity of integrin alpha-1 beta-1 from liver sinusoidal membranes for type IV collagen. FEBS Lett 1991; 288: 241-3.
48. Ruoslahti E, Pierschbacher MD. New perspectives in cell adhesion: RGD and integrins. Science (Washington DC) 1987; 238: 491-7.
49. Argraves WS, Suzuki S, Arai H, Thompson K, Pierschbacher MD, Ruoslahti E. Amino acid sequence of the human fibronectin receptor. J Cell Biol 1987; 105: 1183-90.
50. Wayner EA, Garcia-Pardo A, Humphreys MJ, McDonald JA, Carter WG. Identification of the T-lymphocyte adhesion receptor for an alternative cell attachment domain (CS-1) in plasma fibronectin. J Cell Biol 1989; 109: 1321-30.
51. Panayotou G, End P, Aumailley M, et al. Domains of laminin with growth factor activity. Cell 1989; 48: 989-96.
52. Klagsbrunn M, Baird A. A dual receptor system is required for basic fibroblast growth factor activity. Cell 1991; 67: 229-31.
53. Andres JL, Stanley K, Cheifetz S, Massague J. Membrane-anchored and soluble forms of betaglycan, a polymorphic proteoglycan that binds transforming growth factor-beta. J Cell Biol 1989; 109: 3137-45.
54. Roberts AB, Anzano MA, Lamb LC, Smith JM, Sporn MB. New class of transforming growth factor potentiated by epidermal growth factor. Proc Natl Acad Sci USA 1981; 78: 5339-41.
55. Meyer DH, Bachem MG, Gressner AM. Modulation of hepatic lipocyte proteoglycan synthesis and proliferation by Kupffer cell-derived transforming growth factors type beta 1 and type alpha. Biochem Biophys Res Commun 1990; 171: 1122-9.
56. Win KM, Charlotte F, Mallat A, et al. Mitogenic effect of transforming growth factor-beta 1 on human Ito cells in culture: evidence for mediation by endogenous platelet-derived growth factor. Hepatology 1993; 18: 137-45.
57. Jakowlew SB, Mead JE, Damelpour D, Wu J, Roberts AB, Fausto N. Transforming growth factor beta (TGF-beta) isoforms in rat liver regeneration: messenger RNA expression and activation of latent TGF-beta. Cell Regulation 1991; 2: 535-48.
58. Nakatsukasa H, Nagy P, Evarts RP, Hsia CC, Marsden E, Thorgeirsson SS. Cellular distribution of transforming growth factor-beta 1 and procollagen types I, III, and IV transcripts in carbon tetrachloride-induced rat liver fibrosis. J Clin Invest 1990; 85: 1833-43.
59. Manthey CL, Allan JB, Ellingsworth LR, Wahl SM. In situ expression of transforming growth factor-beta in streptococcal cell wall-induced granulomatous inflammation and hepatic fibrosis. Growth Factors 1990; 4: 17-26.
60. Czaja MJ, Weiner FR, Flanders KC, et al. In vitro and in vivo association of transforming growth factor beta-1 with hepatic fibrosis. J Cell Biol 1989; 108: 2477-82.
61. Tsukamoto H, Home W, Kamimura S, et al. Experimental liver cirrhosis induced by alcohol and iron. J Clin Invest 1995; 96: 620-30.
62. Bissell DM, Wang SS, Jarnagin WR, Roll FJ. Cell-specific expression of transforming growth factor-beta in rat liver. Evidence for autocrine regulation of hepatocyte proliferation. J Clin Invest 1995; 96: 447-55.
63. Castilla A, Prieto J, Fausto N. Transforming growth factors beta-1 and alpha in chronic liver disease: Effects of interferon therapy. N Engl J Med 1991; 324: 933-940.
64. Milani S, Schuppan D, Herbst H, Surrenti C. Expression of transforming growth factor beta, in normal and fibrotic human liver. In: Gressner A, Ramadori G, eds. Molecular and cell biology of liver fibrogenesis. Dordrecht, The Netherlands: Kluwer Academic Publishers, 1992: 254-62.
65. Bachem MG, Meyer D, Melchior R, Sell K-M, Gressner AM. Activation of rat liver perisinusoidal lipocytes by transforming growth factors derived from myofibroblast-like cells. J Clin Invest 1992; 89: 19-27.
66. Masague J. The transforming growth factor beta family. Annu Rev Cell Biol 1990; 6: 597-641.
67. Roberts AB, Sporn MB. The transforming growth factors-beta. In: Sporn MB, Roberts AB, ed. Handbook of experimental pharmacology. Peptide growth factors and their receptors. Heidelberg, Germany: Springer-Verlag, 1990: vol. 95/L, 419-72.
68. Matsuoka M, Pham NT, Tsukamoto H. Differential effects of interleukin 1 alpha, tumour necrosis factor alpha, and transforming growth factor beta-1 on cell proliferation and collagen formation by cultured fat storing cells. Liver 1989; 9: 71-8.
69. Bachem MH, Sell KM, Melchior R, Kropf J, Eller T, Gressner AM. TNF-alpha and TGF beta-1 stimulate fibronectin synthesis and the transdifferentiation of fat storing cells in rat liver to myofibroblasts. Virchows Archiv B Cell Pathol 1993; 63: 123-30.
70. Casini A, Pinzani M, Milani S, et al. Regulation of extracellular matrix synthesis by transforming growth factor beta 1 in human fat-storing cells. Gastroenterology 1993; 105: 245-53.
71. Bachem MG, Riess U, Melchior R, Sell KM, Gressner AM. Transforming growth factors (TGF alpha and TGF beta 1) stimulate chondroitin sulfate and hyluronate synthesis in cultured rat liver fat storing cells. FEBS Lett 1989; 257: 134-7.
72. Edwards DR, Murphy G, Reynolds JJ, et al. Transforming growth factor beta modulates the expression of collagenase and metalloproteinase inhibitor. EMBO J 1987; 6: 1899-904.
73. Overall CM, Wrana JL, Sudek J. Independent regulation of collagenase, 72 kD progelatinase, and metalloendoproteinase inhibitor expression in human fibroblasts by transforming growth factor-beta. J Biol Chem 1989; 264: 1860-9.
74. Kojima S, Rifkin DB. Mechanism of retinoid-induced activation of latent transforming growth factor beta in bovine endothelial cells. J Cell Physiol 1993; 155: 323-32.
75. Blazejewski S, Preaux AM, Mallat A, et al. Human myofibroblast like cells obtained by outgrowth are representative of the fibrogenic cells in the liver. Hepatology 1995; 22: 788-97.
76. Roberts CJ, Birkenmeir TM, McQuillan JJ, et al. Transforming growth factor-beta stimulates the expression of fibronectin and of both subunits of the human fibronectin receptor by cultured human fibroblasts. J Biol Chem 1988; 263: 4586-92.
77. De Bleser PJ, Jannes P, van Buul-Offers SC, et al. Insulin-like growth factor-II/mannose 6-phosphate receptor is expressed on CC14-exposed rat fat-storing cells and facilitates activation of latent transforming growth factor-beta in cocultures with sinusoidal endothelial cells. Hepatology 1995; 21: 1429-37.
78. Friedman SL, Yamasaki G, Wong L. Modulation of transforming growth factor beta receptors of rat lipocytes during the hepatic wound healing response. J Biol Chem 1994; 269: 10551-8.
79. Cheifetz S, Andres JL, Massague J. The transforming growth factor-beta receptor type III is a membrane proteoglycan. Domain structure of the receptor. J Biol Chem 1988; 263: 16984-91.
80. Lopez-Casillas F, Cheifetz S, Doody J, Andres JL, Lane WS, Massague J. Structure and expression of the membrane proteoglycan betaglycan, a component of the TGF-beta receptor system. Cell 1991; 67: 785-95.
81. Border WA, Noble NA, Yamamoto T, et al. Natural inhibitor of transforming growth factor-beta protects against scarring in experimental kidney disease. Nature (London) 1992; 360: 361-4.
82. Shah M, Foreman DM, Ferguson MWJ. Control of scarring in adult wounds by neutralising antibody to transforming growth factor beta. Lancet 1992; 339: 213-14.
83. Border WA, Okuda S, Languino LR, Sporn MB, Ruoslahti E. Suppression of experimental glomerulonephritis by antiserum against transforming growth factor beta 1. Nature (London) 1990; 346: 371-4.
84. Isaka Y, Brees DK, Ikegaya K, et al. Gene therapy by skeletal muscle expression of decorin prevents fibrotic disease in rat kidney. Nature Med 1996; 2: 418-23.
85. Sanderson N, Factor V, Nagy P, et al. Hepatic expression of mature transforming growth factor beta 1 in transgenic mice results in multiple tissue lesions. Proc Natl Acad Sci USA 1995; 92: 2572-6.
86. Ross R, Raines EW, Bower-Pope DF. The biology of platelet derived growth factor. Cell 1986; 46: 155-69.
87. Pinzani M, Gesukado L, Sabbah GM, Abboud HE. Effects of platelet derived growth factor and other polypeptide mitogens on DNA synthesis and growth of cultured rat liver fat storing cells. J Clin Invest 1989; 84: 1786-93.
88. Rieder H, Ramadori G, Meyer zum Buschenfelde K-H. Sinusoidal cells in vitro secrete PDGF like factors stimulating the proliferation of cultured liver myofibroblastic cells. In: Gressner AM, Ramadori G, eds. Molecular and Cell biology of liver fibrogenesis. Dordrecht, The Netherlands: Kluwer Academic Publishers, 1992: 172-6.
89. Marra F, Choudhury GG, Pinzani M, Abboud HE. Regulation of platelet-derived growth factor secretion and gene expression in human liver fat-storing cells. Gastroenterology 1994; 107: 1110-17.
90. Wong L, Yamasaki G, Johnson RJ, Friedman SL. Induction of beta-platelet-derived growth factor receptor in rat hepatic lipocytes during cellular activation in vivo and in culture. J Clin Invest 1994; 94: 1563-9.
91. Friedman SL, Arthur MJP. Activation of cultured rat hepatic lipocytes by Kupffer cell conditioned medium. Direct enhancement of matrix synthesis and stimulation of cell proliferation via induction of platelet derived growth factor receptors. J Clin Invest 1989; 84: 1780-5.
92. Gressner AM, Hoffmann C, Lahme B, Scheckel L. Hepatocyte injury stimulates the mitogenic activation of cultured fat storing cells. In: Wisse E, Wake K, Knook DL, eds. Cells of the hepatic sinusoid. Leiden. The Netherlands: The Kupffer Cell Foundation, 1995: vol. 5, 380-2.
93. Brenzel A, Weiner OH, Gressner AM. Stage-dependent expression of insulin-like growth factor (IGF)-I- and IGF-II-binding sites in rat liver fat storing cells (FSC) during in vitro transformation to myofibroblasts (MFB). In: Wisse E, Wake K, Knook DL, eds. Cells of the hepatic sinusoid. Leiden, The Netherlands: The Kupffer Cell Foundation, 1995: vol. 5, 386-90.
94. Emonard H, Guillouzo A, Lapiere CM, Grimaud JA Human liver fibroblast capacity for synthesizing interstitial collagenase in vitro. Cell Mol Biol 1990; 36: 461-7.
95. Iredale JP, Goddard S, Murphy G, Benyon RC, Arthur MJP. Tissue inhibitor of metalloproteinase-1 and interstitial collagenase expression in autoimmune chronic active hepatitis and activated human hepatic lipocytes. Clin Sci 1995; 89: 75-81.
96. Rockey DC, Maher JJ, Jarnagin WR, Gabbiani G, Friedman SL. Inhibition of rat hepatic lipocyte activation in culture by interferon-gamma. Hepatology 1992; 16: 776-84.
97. Geerts A, Vrijsen R, Schelliack P, Wisse E. Retinol affects the phenotype and protein synthesis of fat storing cell derived myofibroblasts in vitro. In: Wisse E. Knook DL, Decker K, eds. Cells of the hepatic sinusoid. Leiden, The Netherlands: The Kupffer Cell Foundation, 1989: vol. 2, 20-4.
98. Davis BH, Kramer RT, Davidson NO. Retinoic acid modulates rat Ito cell proliferation, collagen, and transforming growth factor beta production. J Clin Invest 1990; 86: 2062-70.
99. Davis BH, Rapp UR, Davidson NO. Retinoic acid and transforming growth factor beta differentially inhibit platelet-derived-growth-factor-induced ito-cell activation. Biochem J 1991; 278: 43-7.
100. Hendriks HFJ, Bosma A, Brouwer A. Fat-storing cells: Hyper- and hypovitaminosis A and the relationships with liver fibrosis. Semin Liver Dis 1993; 13: 72-80.
101. Murphy G, Docherty AJP, Hembry RM, Reynolds JJ. Metalloproteinases and tissue damage. Br J Rheumatol 1991; 30 (Suppl. 1): 25-31.
102. Winwood PJ, Schuppan D, Iredale JP, Kawser CA, Docherty AJP, Arthur MJP. Kupffer cell-derived 95 kDa type IV collagenase/gelatinase B: characterisation and expression in cultured cells. Hepatology 1995; 22: 304-15.
103. Vyas SK, Leyland H, Gentry J, Arthur MJP. Transin (stromelysin) is expressed in early rat lipocyte primary culture. Gastroenterology 1995; 109: 889-98.
104. Arthur MJP, Friedman SL, Roll FJ, Bissell DM. Lipocytes from normal rat liver release a neutral metalloproteinase that degrades basement membrane (type IV) collagen. J Clin Invest 1989; 84: 1076-85.
105. Arthur MJP, Stanley A, Iredale JP, Rafferty JA, Hembry RM, Friedman SL. Secretion of 72 kDa type IV collagenase/gelatinase by cultured human lipocytes: analysis of gene expression, protein synthesis and proteinase activity. Biochem J 1992; 287: 701-7.
106. Herbst H, Heinrichs O, Schuppan D, Milani S, Stein H. Temporal and spatial patterns of transin/stromelysin RNA expression following toxic injury in rat liver. Virchows Archiv B Cell Pathol 1991; 60: 295-300.
107. Iredale JP, Winwood PJ, Kawser CA, Arthur MJP. Lipocyte proliferation in the C. parvum model of macrophage-induced liver injury is associated with expression of 72 kDa type IV collagenase/gelatinase. In: Knook DL, Wisse E. eds. Cells of the hepatic sinusoid. Leiden, The Netherlands: Kupffer Cell Foundation, 1993: vol. 4, 105-8.
108. Iredale JP, Ferris WF, Goddard S, et al. TIMP-1 expression is enhanced relative to interstitial collagenase messenger RNA in experimental liver injury and fibrosis. Hepatology 1996; 24: 176-84.
109. Aimes RT, Quigley JP. Matrix metalloproteinase-2 is an interstitial collagenase - Inhibitor-free enzyme catalyzes the cleavage of collagen fibrils and soluble native type 1 collagen generating the specific 3/4-and 1/4-length fragments. J Biol Chem 1995; 270: 5872-6.
110. Benyon RC, Iredale JP, Goddard S, Winwood PJ, Arthur MJP. Increased expression of tissue inhibitor of metalloproteinases-1 and -2 relative to interstitial collagenase in fibrotic human liver. Gastroenterology 1996; 110: 821-31.
111. Okazaki I, Maruyama K. Collagenase activity in experimental hepatic fibrosis. Nature (London) 1974; 252: 49-50.
112. Perez-Tamayo R, Montfort I, Gonzalez E. Collagenolytic activity in experimental cirrhosis of the liver. Exp Mol Pathol 1987; 47: 300-8.
113. Maruyama K, Feinman L, Fainsilber Z, Nakano M, Okazaki I, Lieber CS. Mammalian collagenase increases in early alcoholic liver disease and decreases with cirrhosis. Life Sci 1982; 30: 1379-84.
114. Iredale JP, Murphy G, Hembry RM, Friedman SL, Arthur MJP. Human hepatic lipocytes synthesize tissue inhibitor of metalloproteinases-1 (TIMP-1): implications for regulation of matrix degradation in liver. J Clin Invest 1992; 90: 282-7.
115. Kordula T, Guttgemann I, Rosejohn S, et al. Synthesis of tissue inhibitor of metalloproteinase-1 (TIMP-1) in human hepatoma cells (HepG2) - up-regulation by interleukin-6 and transforming growth factor-beta 1. FEBS Lett 1992; 313: 143-7.
116. Roeb E, Graeve L, Hoffmann R, Decker K, Edwards DR, Heinrich PC. Regulation of tissue inhibitor of metalloproteinases-1 gene expression by cytokines and dexamethasone in rat hepatocyte primary cultures. Hepatology 1993; 18: 1437-42.
117. Roeb E, Rosejohn S, Erren A, et al. Tissue inhibitor of metalloproteinases-2 (TIMP-2) in rat liver cells is increased by lipopolysaccharide and prostaglandin E(2). FEBS Lett 1995; 357: 33-6.
118. Truden JL, Boros DL. Detection of alpha-2-macroglobulin, alpha-1-protease inhibitor, and neutral protease-antiprotease complexes within liver granulomas of schistosoma mansoni-infected mice. Am J Pathol 1988; 130: 281-8.
119. Murawaki Y, Yamamoto H, Kawasaki H, Shima H. Serum tissue inhibitor of metalloproteinases in patients with chronic liver disease and with hepatocellular carcinoma. Clin Chim Acta 1993; 218: 47-58.
120. Andus T, Gross V, Tran-Thi T-A, Schreiber G, Nagashima M, Heinrich PC. The biosynthesis of acute-phase proteins in primary cultures of rat hepatocytes. Eur J Biochem 1983; 133: 561-71.
121. Leyland H, Gentry J, Arthur MJP, Benyon RC. The plasminogen activating system in hepatic stellate cells. Hepatology 1996; 24: 1172-8.